WARNING: GRAPHIC PHOTOS BELOW A Texas man said he knows “he’ll never be the same” after he contracted a potentially deadly bacterial infection from dipping his toes in the water. Adam Perez, who reportedly was homeless prior to the infection, said that so far he has required several surgeries and has lost most of the flesh on… Read More »
Consumption of dietary supplements sold for weight loss, muscle building, and energy was associated with increased risk for severe medical events in children and young adults compared with consumption of vitamins, according to new research led by Harvard T.H. Chan School of Public Health. The study, published today in the Journal of Adolescent Health, found… Read More »
FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis Print this page NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ — AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic… Read More »
Dr. Mark DeBrincat, a chiropractor and natural health physician also known as “The Good News Doctor,” has a most amazing story of recovery from one of the worst chronic debilitating pain syndromes that I’ve ever heard of, so I asked him to share his journey with you, in the hopes it may motivate you to… Read More »
The HSE has confirmed that the measles outbreak in Co Donegal last week is continuing and has urged everyone who believes that they may have been affected by the illness to contact their GP. Two cases of the illness were confirmed last Wednesday but today there have been another two cases confirmed with three more probable… Read More »
Print this page BLAINVILLE, QC, January 29, 2019 – Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced today that the FDA has approved its supplemental New Drug Application (sNDA) seeking to add moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy (VVA), due to menopause, to the indication of Osphena… Read More »